SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Mkilloran who wrote (18925)2/18/1999 8:43:00 PM
From: VLAD  Read Replies (1) | Respond to of 23519
 
martin,

Good review on opinions of the past. I have to give Charlie O credit for sticking to his guns and not down grading Vivus based on the fact that the stock price continues to be low 8 months after he gave a buy rating when the stock was priced at $7.00. Many analysts will down grade a stock when it is at or near a 52 week low--such advise is like closing the barn door after the horse gets out. I also feel that if the two remaining analysts had any balls they would upgrade Vivus on valuation alone(Just wait and see--they will do their upgrades AFTER Vivus announces a domestic partner and AFTER the stock makes a significant run up. Who needs that type of analysis?). They can safely sit on their hold recommendations while Vivus is in the dumps and look like they are "right".